zithromax and Buruli-Ulcer

zithromax has been researched along with Buruli-Ulcer* in 1 studies

Other Studies

1 other study(ies) available for zithromax and Buruli-Ulcer

Article	Year
Case Report: A New Mycobacterium ulcerans Genotype Causing Buruli Ulcer in Côte d'Ivoire. The American journal of tropical medicine and hygiene, 2021, 04-05, Volume: 104, Issue:5 Mycobacterium ulcerans, the opportunistic pathogen causing Buruli ulcer, is reported to affect rural populations in 36 tropical countries. We report one case of Buruli ulcer in a peri-urban area in Côte d'Ivoire, confirmed by whole genome sequencing which indicated a M. ulcerans genotype previously unreported in Côte d'Ivoire. Topics: Anti-Bacterial Agents; Azithromycin; Buruli Ulcer; Cities; Cote d'Ivoire; Genome, Bacterial; Genotype; Humans; Male; Middle Aged; Mycobacterium ulcerans; Phylogeny; Rifampin; Whole Genome Sequencing	2021

Article

Year

Case Report: A New Mycobacterium ulcerans Genotype Causing Buruli Ulcer in Côte d'Ivoire.

The American journal of tropical medicine and hygiene, 2021, 04-05, Volume: 104, Issue:5

Mycobacterium ulcerans, the opportunistic pathogen causing Buruli ulcer, is reported to affect rural populations in 36 tropical countries. We report one case of Buruli ulcer in a peri-urban area in Côte d'Ivoire, confirmed by whole genome sequencing which indicated a M. ulcerans genotype previously unreported in Côte d'Ivoire.

Topics: Anti-Bacterial Agents; Azithromycin; Buruli Ulcer; Cities; Cote d'Ivoire; Genome, Bacterial; Genotype; Humans; Male; Middle Aged; Mycobacterium ulcerans; Phylogeny; Rifampin; Whole Genome Sequencing

2021